Pamidronic acid is a bisphosphonate drug used to prevent bone loss and treat conditions like osteoporosis, Paget’s disease, and hypercalcemia of malignancy. It works by inhibiting osteoclast-mediated bone resorption, strengthening bone density. It is grouped under the following drug class(es): Antiplatelets. Its therapeutic use is listed as anti-osteoporosis agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Aredia, Ribodroat and Pamidronate. Its PubChem CID is 4674.
Pamidronic acid
| CAS No | 40391-99-9 |
|---|---|
| Molecular Formula | C3H11NO7P2 |
| Molecular Weight | 235.07 g/mol |
| Synonyms | (3-amino-1-hydroxy-1-phosphonopropyl)phosphonic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pamidronic acid is a bisphosphonate drug used to prevent bone loss and treat conditions like osteoporosis, Paget’s disease, and hypercalcemia of malignancy. It works by inhibiting osteoclast-mediated bone resorption, strengthening bone density.
The listed CAS number is 40391-99-9.
The listed molecular formula is C3H11NO7P2.
The listed molecular weight is 235.07 g/mol.
(3-amino-1-hydroxy-1-phosphonopropyl)phosphonic acid.
The source lists Aredia, Ribodroat and Pamidronate.